<DOC>
	<DOCNO>NCT00193934</DOCNO>
	<brief_summary>The researcher propose may corpus invasion , rather tumour volume per se , one important determinant ultimate outcome cervix cancer . The aim propose prospective , multicentre study , confirm result retrospective study , specifically corpus invasion tumour volume contribute important prognostic information provide currently use International Federation Gynecology Obstetrics ( FIGO ) stag system . A successful outcome would important implication stag , management well biologic understand behaviour cervical cancer .</brief_summary>
	<brief_title>Magnetic Resonance Imaging ( MRI ) Staging Cervix Cancer</brief_title>
	<detailed_description>This prospective , multicentre , prognostic factor , follow-up study . The study design simple possible : newly diagnose cervical cancer patient key prognostic variable collect baseline . The treatment receive documented end treatment patient follow first relapse survival . Registration patient study undertaken EUA , biopsy confirm diagnosis , anatomic stag diagram MRI do treatment commence . Treatment must curative intent ( termed radical therapy ) otherwise discretion investigator . Radical hysterectomy alone , hysterectomy follow adjuvant radiotherapy , radical chemo-radiotherapy radical radiotherapy allow . Details plan give treatment regimen record . All patient follow trial data document time registration : - Age - ECOG performance status - smoking status - date histological diagnosis - histologic type feature - present haemoglobin - standard FIGO stag - maximum clinical tumour diameter measure EUA - detail stag diagram drawn EUA - nodal status ( surgical pathology CT MRI PET available ) - date MRI - MRI tumour diameter - presence absence corpus invasion MRI - plan treatment detail All patient assess pre-treatment , immediately follow treatment follow local control survival yearly interval date registration . It intend collect follow information patient one year final patient register study .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1 . Newly diagnose , biopsy proven carcinoma uterine cervix . 2 . Squamous cell , adenocarcinoma , adenosquamous large cell carcinoma histology . 3 . FIGO Stage Ib IVa . 4 . Maximum clinical tumour diameter record . 5 . MRI do within 30 day prior registration . 6 . Intention treat radically 7 . Treatment yet start . 8 . Written informed consent . 9 . Available followup . 1 . Lymphoma , small cell carcinoma melanoma histology . 2 . Previous hysterectomy 3 . Pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Women 's Health</keyword>
	<keyword>Multidisciplinary , multicentre prospective study</keyword>
	<keyword>Cancer : mechanisms growth , invasion , metastasis</keyword>
	<keyword>Figo Stages cervical cancer</keyword>
	<keyword>Advances diagnosis use radiological method</keyword>
	<keyword>Quantitative Magnetic Resonance Imaging</keyword>
	<keyword>Patient Management Strategies</keyword>
	<keyword>Selecting patient therapy</keyword>
</DOC>